LNP formulations produce strong immune responses, data shows
Drug Discovery World
FEBRUARY 15, 2024
The RNA technology company conducted the work in collaboration with the lab of Professor De Geest at Ghent University, and describes how delivery of mRNA encoded antigens in LNPs comprising a novel class of ionisable lipids enhances the induction of antigen-specific immune responses while reducing undesired off-target expression in the liver, thereby (..)
Let's personalize your content